– USA, CA – ResMed (NYSE: RMD | ASX: RMD) today announced the election of digital health leaders Dr. Desney Tan (Ph.D.) and Dr. John Hernandez (Ph.D.) to its Board of Directors, bringing diverse perspectives to the board.
“We’re pleased to welcome Desney Tan and John Hernandez to ResMed’s Board. We are fortunate to leverage their expertise in digital health and health economics outcomes research as we continue to expand our leadership in digital health and improve the lives of millions of people around the world,” said Founder and Board Chairman, Peter Farrell.
About Desney Tan
Dr. Tan has lived, worked, and led organizations across the globe. He is actively involved in Microsoft’s Global Diversity and Inclusion community (serving as ally, mentor, sponsor, initiative leader, etc.) as well as its Asian Employee Resource Group (promoting the heritage of Asian ethnicity by sharing cultures and languages, developing Asian leaders, and ensuring representation of diverse perspective in strategy, innovation, product development, and business operations).
Desney Tan is VP and managing director for Health and Life Science R&D at Microsoft, where he’s worked in various research roles since 2004. He is also an affiliate professor of computer science and engineering at the University of Washington since 2007, where he cofounded the National Science Foundation Center for Sensorimotor Neural Engineering and chaired its industry advisory board.
Tan is the named inventor on more than 100 granted patents, and author of numerous academic publications on topics relevant to ResMed’s long-term strategy such as artificial intelligence, machine learning, and human-computer interaction. He serves as senior advisor and chief technologist to IntuitiveX, a medical device and life sciences innovation partner and catalyst, and as an advisor to Proprio, which is developing an advanced surgical navigation platform. He also achieved the rank of Lieutenant in the Singapore Armed Forces over two-and-a-half years of active duty service and still serves in its reserves.
Tan has a Ph.D in computer science from Carnegie Mellon University, and a Bachelor of Science in computer engineering from the University of Notre Dame.
About John Hernandez
Diversity and health equity considerations play an important role in Dr. Hernandez’s work at Google where he works closely with national experts in health diversity and product inclusion. Several of his recent initiatives have included specific objectives to promote health equity and improve access for vulnerable populations.
John Hernandez is the clinical director and head of clinical research, health economics, and outcomes research at Google. Over the past 20 years, he has also led similar work at Verily, Abbott Laboratories, and Boston Scientific Corporation. Before those, he served in management and consulting roles at the RAND Corporation, Quintiles, PwC, and the American Society of Internal Medicine. He currently serves on the board of Carmat, SA (EPA: ALCAR), a French artificial heart company.
Hernandez has held teaching and advisory positions at Stanford University, Stanford Clinical Excellence Research Center, the University of Southern California, and the University of Washington; is widely published in scientific journals; and lectures frequently on topics relevant to ResMed’s long-term strategy such as digital health strategy, real-world evidence strategies, and value-based payment systems.
Hernandez has a Ph.D. and Master in health policy from the RAND Graduate School in Santa Monica, Calif., and a Bachelor’s in political science from the University of North Carolina at Chapel Hill.
About ResMed
At ResMed, we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care to set of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
For more information: https://www.resmed.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.